CAPA Annual Conference - 2005 CME

Recent Advances in Diagnosis, Testing, Treatment and Prevention of Transmission of HSV-2

Category: CME
Date:  09/30/2005
Time: 8:00 am - 9:15 am
Facility: Palm Springs Convention Center
Location: 
Description: 

Understand the role of new FDA-approved, highly accurate laboratory-based HSV antibody test (HerpeSelect 1 and 2) in the diagnosis of herpes simplex virus infection (HSV).
Describe recent changes in HSV-1 and HSV–2 incidence and prevalence and implications for clinical practice.

Explain the common presentations of genital HSV infection including:

1- “classic” painful vesiculopapular and ulcerative disease
2- atypical presentation – mostly lower genital tract inflammatory condition soften unrecognized as due to HSV infection
3- asymptomatic infection including asymptomatic viral shedding

Describe pharmacologic management of genital HSV infection – initial episodic and suppressive approaches to treatment – including approaches to successfully addressing patient and system barriers to successful therapy. Describe approaches to significantly reduce HSV-2 transmission including daily suppressive therapy and the use of barriers.

Understand proposed prenatal screening algorithms for HSV-2/HSV-1

Speaker(s): Gary A. Richwald, M.D.